Akanda Corp. (AKAN) Stock Price & Analysis
Akanda Corp. (AKAN) closed at USD 1.01 on Friday, October 23, 2026, down 12.17% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 1.15; the Oct 23, 2026 session ranged USD 1.01–1.28 on volume of 471,701 shares. Market capitalization is $2.67M, with a 52-week range of USD 1–78.9 (NCM). Source: Nexqual, retrieved October 24, 2026 at 07:42 UTC.
Also available as compact Markdown for AI agents: nexqual.com/AKAN.md
Key facts (AKAN)
- Analysts: None.
- Total return with dividends: 1Y -98.0% vs S&P 500 +13.4%; 5Y -100.0% vs S&P 500 +76.9%.
Analysts (AKAN)
Consensus None.
Total return (dividends reinvested) (AKAN)
| 1Y (from 2025-10-24) | 5Y (from 2022-03-14) | |
|---|---|---|
| Total return | -98.0% | -100.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -98.0% | -93.9% |
| Volatility (annualized) | 215.8% | 184.5% |
| Max drawdown | -98.2% (May 2026→Oct 2026) | -100.0% (Apr 2022→Oct 2026) |
AKAN suppliers, customers and competitors (named in its 20-F)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Halo Collective | “In September 2021, we entered into a share purchase agreement with Halo, a publicly-traded,” |
Quoted from the company's 20-F filed Jun 9, 2026.
AKAN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 07:42 UTC)
| Price | USD 1.01 |
|---|---|
| Change | ▼ 12.17% (down) |
| Previous Close | USD 1.15 |
| Open | USD 1.23 |
| Day Range | USD 1.01 – 1.28 |
| 52-Week Range | USD 1 – 78.9 |
| Volume | 471,701 shares |
| Market Cap | $2.67M |
| Exchange | NCM |
Technical Analysis (AKAN)
Nexqual's technical model rates AKAN "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 24, 2026 at 07:42 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 18.53 (oversold) |
| vs SMA50 | Below (USD 2.89) |
| MACD | -0.6 (negative) |
Analyst Ratings (AKAN)
Wall Street analysts rate AKAN "None", per Nexqual as of October 24, 2026 at 07:42 UTC.
| Consensus Rating | None |
|---|
Earnings (AKAN)
Source: Nexqual, October 24, 2026 at 07:42 UTC.
Financials & Fundamentals (AKAN)
| Total Revenue | $662,469 |
|---|---|
| Gross Margin | -11.99% |
| Operating Margin | -1191.48% |
| Profit Margin | +0.00% |
| Current Ratio | 0.22 |
| Total Cash | $755,238 |
| Total Debt | $18.57M |
Source: Nexqual, October 24, 2026 at 07:42 UTC.
Financial Health Score (AKAN)
Nexqual rates Akanda Corp.'s overall financial health "Weak" across five dimensions, as of October 24, 2026 at 07:42 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $755K cash vs $19M debt |
| Cash Flow | Weak — Operating cash flow -$10M (TTM) |
| Efficiency | Mixed — No data |
Ownership (AKAN)
| Insider Ownership | +0.59% |
|---|---|
| Institutional Ownership | +0.08% |
| Shares Outstanding | 2.39M |
| Float | 531,210 |
| Short % of Float | +8.45% |
Source: Nexqual, October 24, 2026 at 07:42 UTC.
Leadership (AKAN)
Akanda Corp. is led by Christopher Robert Cooper BBA, CEO & Director, per Nexqual as of October 24, 2026 at 07:42 UTC.
| CEO & Director | Christopher Robert Cooper BBA |
|---|---|
| Chief Financial Officer | Gurcharn Deol B.A., M.A. |
| VP, COO & Director of First Towers | Francisco Juarez |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals, Inc. | USD 40.7 | ▼ 3.26% |
| BHC | Bausch Health Companies Inc. | USD 6.44 | ▼ 0.77% |
| HCM | HUTCHMED (China) Limited | USD 14.36 | ▲ 0.56% |
| AMLX | Amylyx Pharmaceuticals, Inc. | USD 27.2 | ▼ 4.8% |
| RGC | Regencell Bioscience Holdings L | USD 7.67 | ▼ 21.81% |
| LQDA | Liquidia Corporation | USD 42.65 | ▲ 7.46% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 07:42 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt